| Gayla Schmidt Perkins, ACMHC | |
|
185 N Vernal Ave Ste 1, Vernal, UT 84078-2100 | |
| (435) 789-1305 | |
| (307) 782-3122 |
| Full Name | Gayla Schmidt Perkins |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 185 N Vernal Ave Ste 1, Vernal, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104475359 | NPI | - | NPPES |
| 4987452-6009 | Other | UT | DOPL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 4987452-6009 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Gayla Schmidt Perkins, ACMHC 185 N Vernal Ave Ste 1, Vernal, UT 84078-2100 Ph: (435) 789-1305 | Gayla Schmidt Perkins, ACMHC 185 N Vernal Ave Ste 1, Vernal, UT 84078-2100 Ph: (435) 789-1305 |
News Archive
An FDA warning regarding increased suicide risk in children and teens taking antidepressant drugs has led to an overall decrease in antidepressant prescribing for young patients, reports a study in the November issue of Medical Care. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.
The RCGP is calling for GPs to review personal health budget care plans, warning that patients' health needs may not be met if their allocated funds run out.
Neurotechnology, a provider of high-precision biometric identification and object recognition technologies, has released new versions of the company's product line of Software Development Kits (SDKs) for biometric fingerprint, face, iris and voice identification and object recognition.
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced a focusing of its resources on advancing its core proprietary programs through key clinical inflection points in 2011 and 2012, and supporting strategic alliances with Roche and Baxter such as validation of Halozyme's commercial scale manufacturing process to produce kilogram quantities of enzyme.
In a Brief Communication, published July 29, 2021 in the journal Transplant Infectious Disease, a team of physician-scientists at University of California San Diego School of Medicine found that solid organ transplant recipients who were vaccinated experienced an almost 80 percent reduction in the incidence of symptomatic COVID-19 compared to unvaccinated counterparts during the same time.
› Verified 5 days ago
Michelle Dawn Smith, CMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 89 W Main St, Vernal, UT 84078 Phone: 435-790-5628 | |
Lilyan Harrison Baker, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1140 W 500 S, Vernal, UT 84078 Phone: 435-789-6300 Fax: 435-789-6325 | |
Frances Barnett Lewis, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1140 W 500 S, Vernal, UT 84078 Phone: 435-789-6300 Fax: 435-789-6325 | |
Andrea Smith, Counselor Medicare: Not Enrolled in Medicare Practice Location: 134 W Main St, Vernal, UT 84078 Phone: 801-375-4240 Fax: 801-375-4241 | |
Kathryn Colver, Counselor Medicare: Not Enrolled in Medicare Practice Location: 185 N Vernal Ave Ste 1, Vernal, UT 84078 Phone: 435-789-1305 | |
Jordan Witbeck, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1140 W 500 S Ste 9, Vernal, UT 84078 Phone: 435-789-6300 Fax: 435-725-6325 |